




💊 Calcium channel blockers (CCBs) are used in the treatment of many cardiovascular conditions including hypertension and angina so needless to say they easily make the top 200 drugs prescribed.⠀
⠀
👉🏻 They are divided into subclasses, non-dihydropyridines, and dihydropyridines and differ by their pharmacokinetic properties, clinical uses, response, and selectivity. ⠀
⠀
👉🏻 Dihydropyridine CCBs end in the suffix ‘-ine’: ⠀
⠀
-AmlodipINE⠀
-NicardipINE⠀
-NifedipINE⠀
-NimodipINE⠀
-FelodipINE⠀
⠀
👉🏻 Non-dihydropyridine CCBs don’t end in the suffix ‘-ine’ hinted by the name of the subclass, NOn-dihydropyridINE:⠀
⠀
-Verapamil⠀
-Diltiazem⠀
⠀